Healthcare News

Press Release Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma FDA sets Prescription Drug User Fee Act (PDUFA) review response date by 30 April 2027Two NDAs filed in major markets, with...

Communiqué de presseNicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome La FDA a fixé la date de réponse à l’examen de la NDA dans le cadre du Prescription Drug User...

Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026...

Louvain-La-Neuve, Belgique, 27 août 2026, 7h00 - IBA (Ion Beam Applications S.A.), annonce aujourd’hui ses résultats consolidés pour le premier semestre 2026, avec une performance conforme aux...

Junshi Biosciences announced its 2026 interim financial results and provided corporate updates.

RYONCIL Market Share Expands; Phase 3 Back Pain Trial Completes Treatment Financial Results and Operational Update for Full Year Ended June 30, 2026 NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) --...

LOUISVILLE, Ky., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, is grateful to be selected as a pharmacy partner by Revolution Medicines for...

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital...

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways...